Literature DB >> 23534471

Use of traditional Chinese medicine in Chinese patients with coronary heart disease.

Xiang Yu Guo1, Jing Liu, Jun Liu, Hong Juan Li, Yue Qi, Lan Ping Qin, Miao Wang, Dong Zhao.   

Abstract

OBJECTIVE: To study the use of traditional Chinese medicine (TCM) or both TCM and guideline-recommended Western medicine (WM) in Chinese patients with coronary heart disease (CHD).
METHODS: A cross-sectional nationwide survey of 2803 CHD outpatients was completed by collecting information, including general demographic data, disease history, and use of drugs (including TCM and WM).
RESULTS: Of the 2712 CHD outpatients with complete drug treatment data, only 3.1% received TCM without any WM for CHD, 30.0% received both TCM and WM recommended by current CHD guidelines, and 66.9% received only WM. Patients with a longer history of CHD or with a history of stroke, were more likely to use TCM. However, 90.6% of CHD patients who used TCM also used certain WM. Furthermore, patients who used more types of TCM tended to use much less WM recommended by current guidelines.
CONCLUSION: A substantial proportion of Chinese CHD outpatients use both TCM and WM for secondary prevention of CHD. It is important to assess the effect of combined TCM and WM on major clinical outcomes in Chinese CHD patients.
Copyright © 2013 The Editorial Board of Biomedical and Environmental Sciences. Published by China CDC. All rights reserved.

Entities:  

Keywords:  Coronary heart disease; Guidelines; Traditional Chinese medicine

Mesh:

Year:  2013        PMID: 23534471     DOI: 10.3967/0895-3988.2013.04.009

Source DB:  PubMed          Journal:  Biomed Environ Sci        ISSN: 0895-3988            Impact factor:   3.118


  10 in total

Review 1.  Traditional Chinese medication for cardiovascular disease.

Authors:  Pan-Pan Hao; Fan Jiang; Yu-Guo Chen; Jianmin Yang; Kai Zhang; Ming-Xiang Zhang; Cheng Zhang; Yu-Xia Zhao; Yun Zhang
Journal:  Nat Rev Cardiol       Date:  2014-11-11       Impact factor: 32.419

2.  Effect of Shenzhu Guanxin Recipe () on patients with angina pectoris after percutaneous coronary intervention: A prospective, randomized controlled trial.

Authors:  Dan-Ping Xu; Huan-Lin Wu; Tao-Hua Lan; Xia Wang; Xiao-Gang Sheng; Yu Lin; Song Li; Chao-Yang Zheng
Journal:  Chin J Integr Med       Date:  2015-06-11       Impact factor: 1.978

3.  Heart healthy integrative nutritional counseling (H2INC): Creating a Chinese medicine + western medicine patient education curriculum for Chinese Americans.

Authors:  Evelyn Y Ho; Joseph Acquah; Cewin Chao; Genevieve Leung; Don C Ng; Maria T Chao; Abby Wang; Shannon Ku; Wanyi Chen; Choi Kwun Yu; Shuwen Xu; Melissa Chen; Jane Jih
Journal:  Patient Educ Couns       Date:  2018-08-09

Review 4.  A review on the traditional Chinese medicinal herbs and formulae with hypolipidemic effect.

Authors:  Tung-Ting Sham; Chi-On Chan; You-Hua Wang; Jian-Mei Yang; Daniel Kam-Wah Mok; Shun-Wan Chan
Journal:  Biomed Res Int       Date:  2014-07-07       Impact factor: 3.411

5.  Practice of Comparative Effectiveness Research to Identify Treatment Characteristics of Similar Chinese Patent Medicine for Angina Pectoris.

Authors:  Hongbo Cao; Ping Wang; Nan Li; Dan Liu; Junshao Ma; Ruihong Fan; Zhihuan Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2017-08-13       Impact factor: 2.629

6.  A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Taoren Honghua Jian granule in patients with stable coronary artery disease.

Authors:  Yiru Wang; Yiyi Zhang; Yiyue Du; Ying Yang; Jing Wei; Na Zhang; Meijiao Mao; Wenting Du; Ping Liu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 7.  Evidence and Potential Mechanisms of Traditional Chinese Medicine for the Adjuvant Treatment of Coronary Heart Disease in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis with Trial Sequential Analysis.

Authors:  Yu Wei; Qi-You Ding; Chak Yeung; Yi-Shan Huang; Bo-Xun Zhang; Li-Li Zhang; Run-Yu Miao; Sha Di; Lin-Hua Zhao; Xiao-Lin Tong
Journal:  J Diabetes Res       Date:  2022-08-31       Impact factor: 4.061

8.  The Protective Effect of Liquiritin in Hypoxia/Reoxygenation-Induced Disruption on Blood Brain Barrier.

Authors:  Mengting Li; Jia Ke; Yiqing Deng; Chunxiang Chen; Yichen Huang; Yuefeng Bian; Shufen Guo; Yang Wu; Hong Zhang; Mingyuan Liu; Yan Han
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810

9.  Clinical Study for Safety Evaluation of GXN Tablets Combined with Aspirin in Long-Term Treatment of Coronary Heart Disease.

Authors:  Mingjie Zi; Ruiqi Li; Fang Lu; Qingna Li; Yang Zhao; Huijuan Jia; Mingyue Sun; Qiaoning Yang; Panbo Qiu; Eryang Wei; Shuge Wang; Rui Li; Wantong Zhang; Weiyi Cao; Yanling Li; Hao Xu; Rui Gao
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-07       Impact factor: 2.629

Review 10.  Current Status and Evaluation of Randomized Clinical Trials of Traditional Chinese Medicine in the Treatment of Cardiovascular Diseases.

Authors:  Xi Guo; Xiaojun Chen; Jinlan Chen; Zhiping Tan; Yifeng Yang; Hong Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-12       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.